Impact Factor
3.44
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.63
1,019 total citations
h5-index
33
h5 depth signal
Cited share
71.2%
289 of 406
Total citations
1,019
Citation footprint
Metric signal
2.60
External metric anchor
Self-citation
17.5%
178 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
697
United Kingdom
382
Canada
330
Italy
275
Germany
261
Citing Fields of Research
Hematology
2,207
Musculoskeletal Disorders
296
Clinical Laboratory Science
82
Genetics & Genomics
71
Obstetrics/Gynecology
49
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,845
Articles tracked across the journal lifetime
Indexed publication set
406
289 cited publications
Last 12 months
280
23.3 publications/month
Open access share
41.4%
116 OA publications in the last year
Leading citing country
United States
697 citing publications
Leading citing field
Hematology
2,207 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v4n1,Jan. 1998-
v4n1,Jan. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Issuing & Sponsoring Bodies
Contributor
World Federation of Hemophilia
Broad Categories
Hematology
MeSH Descriptors
Hemophilia A
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1111/hae.70423
Open DOI
Association of TNFAIP3 Polymorphisms With Bleeding Phenotypes and FVIII Inhibitor Development in Patients With Hemophilia A: A Case‐Control Study
Background: Hemophilia A is an X‐linked bleeding disorder caused by factor VIII (FVIII) deficiency. While F8 gene mutations are the primary cause, immune and inflammatory pathways contribute to variability in clinical phenotype and FVIII...
03
DOI 10.1111/hae.70427
Open DOI
100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD
Introduction: von Willebrand disease (VWD) is a prevalent bleeding disorder resulting from deficiencies and/or defects in von Willebrand factor (VWF). Accurately diagnosing VWD, particularly distinguishing between qualitative defects (ty...
04
DOI 10.1111/hae.70420
Open DOI
Population Pharmacokinetics of Plasma‑Derived Factor X Using Clotting and Chromogenic Assays: A WAPPS‑Hemo Model
Background: Hereditary factor X (FX) deficiency is a rare autosomal recessive bleeding disorder for which individualized pharmacokinetic (PK) assessment can support optimized prophylactic management. The WAPPS‐Hemo platform enables popul...
05
DOI 10.1111/hae.70426
Open DOI
Synovial Metal Binding Proteins in Haemophilic Arthropathy: Potential Biomarkers and Therapeutic Targets
Background: Haemophilic arthropathy (HA) is a chronic joint disease in haemophiliac patients, driven by recurrent bleeding and distinct from osteoarthritis (OA) and rheumatoid arthritis (RA) in its pathogenesis, including metal ion accum...
06
DOI 10.1111/hae.70425
Open DOI
Perioperative Management in Persons With Haemophilia on Rebalancing Therapies: A Narrative Review
Introduction: Perioperative management in haemophilia often requires on‐demand use of clotting factor concentrates (CFC) and/or bypassing agents. Rebalancing agents (fitusiran, concizumab, marstacimab) offer a novel approach to prophylax...
07
Background: Bleeding disorder of unknown cause (BDUC) is increasingly recognized in patients with clinically significant bleeding despite normal haemostatic testing. The International Society on Thrombosis and Haemostasis (ISTH) recently...
08
DOI 10.1111/hae.70413
Open DOI
Enhanced Functional Independence Score for Haemophilia (E‐FISH) for Early Detection of Musculoskeletal Changes
Background: The functional independence score in haemophilia (FISH) is a widely used performance‐based assessment tool designed to evaluate musculoskeletal function in children with haemophilia (CWH). Nevertheless, FISH exhibits a ceilin...
09
10
DOI 10.1111/hae.70424
Open DOI
Implications of Glucagon‐Like Peptide‐1 Signaling for Hemophilic Arthropathy, Joint Inflammation, and Cartilage Degeneration: A Narrative Review
Introduction: Hemophilic arthropathy (HA) is a progressive, inflammatory joint disease that develops despite effective control of bleeding in people with hemophilia (PWH). Increasing evidence suggests that HA is initiated and then mainta...
Bibliographical & Catalog Notes
Title from cover.
Issue for Jan. 1995 also called "Launch issue" and dated Oct. 1994.
Some v. have supplements.
Also issued online.
Vol. 1 no.1 (1995)19990106 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper